Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Genomic Insights Into Risperidone Treatment Outcomes in Children and Adolescents: Experience From a Psychiatric Hospital Serving Rural Youth.

Clinical pharmacology and therapeutics·2026

Same author

Community Partnerships in Clinical Research: A Framework for Sustainability and Resilience.

Clinical pharmacology and therapeutics·2026

Same author

Seasons of Growth: Reflections on the CPT Editor-in-Training Program.

Clinical pharmacology and therapeutics·2025

Same author

Ibrexafungerp: Mechanism of Action, Clinical, and Translational Science.

Clinical and translational science·2025

Same author

Progress in Pharmacogenomics Implementation in the United States: Barrier Erosion and Remaining Challenges.

Clinical pharmacology and therapeutics·2025

Same author

Perspectives on Using Pharmacogenomics to Guide Tobacco Cessation: Survey Results From an American Indian Community.

Clinical and translational science·2025

Search research articles

Related Experiment Video

Updated: Oct 5, 2025

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

Published on: April 1, 2019

Keeping pace with CYP2D6 haplotype discovery: innovative methods to assign function.

Karen E Brown^1,2, Jack W Staples^1,2, Erica L Woodahl^1,2

¹Department of Biomedical & Pharmaceutical Sciences, Skaggs School of Pharmacy, University of Montana, Missoula, MT 59812, USA.

Pharmacogenomics

|January 27, 2022

Summary

New high-throughput methods are needed to understand the function of CYP2D6 gene variants. This will improve pharmacogenomic accuracy and personalize patient treatment.

Keywords:

CYP2D6 drug metabolism genotype pharmacogenetics pharmacogenomics phenotype

More Related Videos

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Published on: March 28, 2017

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

Related Experiment Videos

Last Updated: Oct 5, 2025

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

Published on: April 1, 2019

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Published on: March 28, 2017

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

Area of Science:

Pharmacogenomics
Drug Metabolism
Genetics

Background:

The CYP2D6 gene is crucial for drug metabolism, but many of its haplotypes have unknown functions.
Traditional methods for characterizing gene function are insufficient for the growing complexity of pharmacogenomic research, especially with diverse populations.

Purpose of the Study:

To address the challenge of assigning function to unknown CYP2D6 haplotypes.
To explore innovative, high-throughput technologies for accurate functional characterization of CYP2D6 variants.

Main Methods:

Review of evolving innovative approaches for CYP2D6 haplotype functional assignment.
Discussion of potential integration of these technologies into cohesive processes.

Main Results:

Promising technologies include ADME-optimized prediction frameworks, machine learning, deep mutational scanning, and phenoconversion predictions.
These methods offer high-throughput capabilities essential for complex pharmacogenes like CYP2D6.

Conclusions:

Accurate phenotypic assignment for CYP2D6 is critical for pharmacogenomic utility.
Implementing these advanced approaches can significantly enhance personalized medicine and treatment strategies.